# Inmune Bio, Inc.: Form 8-K, filed Jun 30, 2025

- Company: [Inmune Bio, Inc.](/companies/inmb.md) (CIK 1711754)
- Form: 8-K
- Filed: 2025-06-30
- Accepted by EDGAR: Jun 30, 2025, 16:31 ET
- Period: 2025-06-27
- Accession: 0001213900-25-059690
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/ea0247461-8k_inmune.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711754/000121390025059690/ea0247461-8k_inmune.htm

Filed Jun 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-059690. Last ingested by Listed: Oct 29, 2026, 07:41 ET. No prices; not investment advice.